Logo Logo
Help
Contact
Switch Language to German

Ilmer, Matthias and Guba, Markus Otto (2022): Liver Transplant Oncology: Towards Dynamic Tumor-Biology-Oriented Patient Selection. In: Cancers, Vol. 14, No. 11, 2662

Full text not available from 'Open Access LMU'.

Abstract

While liver transplantation was initially considered as a curative treatment modality only for hepatocellular carcinoma, the indication has been increasingly extended to other tumor entities over recent years, most recently to the treatment of non-resectable colorectal liver metastases. Although oncologic outcomes after liver transplantation (LT) are consistently good, organ shortage forces stringent selection of suitable candidates. Dynamic criteria based on tumor biology fulfill the prerequisite of an individual oncological prediction better than traditional morphometric criteria based on tumor burden. The availability of specific (neo-)adjuvant therapies and customized modern immunosuppression may further contribute to favorable post-transplantation outcomes on the one hand and simultaneously open the path to LT as a curative option for advanced stages of tumor patients. Herein, we provide an overview of the oncological LT indications, the selection process, and expected oncological outcome after LT.

Actions (login required)

View Item View Item